Eli Lilly and Company Other Liabilities

Eli Lilly and Company (LLY.DE) currently reports a other liabilities of $0 as of June 2026. That compares with $83B in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Eli Lilly and Company's other liabilities history and peer comparisons.

Eli Lilly and Company's other liabilities decreased from $83B to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eli Lilly and Company reported $0 in other liabilities as of June 2026. That compares with $83B in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eli Lilly and Company, and consider following LLY.DE for alerts when major investors trade the stock.

Eli Lilly and Company is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LLY.DE with unrelated industries.